Source: Accounting Today: IRS Watch
China’s securities regulator blacklisted six executives for their role in a $4.2 billion accounting scandal at Kangmei Pharmaceutical Co., one of the country’s biggest drugmakers.

Read More: China blacklists six executives linked to .2B fraud